| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/13/1987 | EP0221293A1 7,8,9,10-Tetrahydro-6-oxo-6H-dibenzo[b,d]pyranyloxy-propanes |
| 05/12/1987 | US4665224 Ester of (+) 6-methoxy-α-methyl-2-naphthalene acetic acid having mucosecretolytic, anti-inflammatory, analgesic, antipyretic activity, a process for its preparation and pharmaceutical compositions thereof |
| 05/12/1987 | US4665187 Certain 1,2,3,6-tetrahydro-pyridyl-N-lower-alkanoyl-pyridines as intermediates |
| 05/12/1987 | US4665182 Biopterin analogs |
| 05/12/1987 | US4665157 Oligopeptide analgesics |
| 05/12/1987 | US4665095 Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion |
| 05/12/1987 | US4665094 Oculoselective beta-blockers for treatment of elevated intraocular pressure |
| 05/12/1987 | US4665083 Iminothiazolidine derivatives |
| 05/06/1987 | EP0221032A2 Sodium salt of etodolic acid and process for its preparation |
| 05/06/1987 | EP0221019A2 Peptides |
| 05/06/1987 | EP0220878A2 Ethanolamine compounds |
| 05/06/1987 | EP0220845A1 Heterocyclic compounds and their preparation and use |
| 05/06/1987 | EP0220805A2 Multiphase tablet and process for the preparation thereof |
| 05/06/1987 | EP0220704A1 5-Naphthyl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants |
| 05/06/1987 | EP0220696A2 Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety |
| 05/05/1987 | US4663352 Use of some alkanoyl L-carnitines for the therapeutical treatment of idiopathic and induced Parkinsonism |
| 05/05/1987 | US4663350 Unsaturated diphenylazomethine derivatives, their preparation and pharmaceutical compositions containing them |
| 05/05/1987 | US4663349 Rectally absorbable form of L-dopa |
| 05/05/1987 | US4663328 3-Phenyl-tetrahydropyridine derivatives, and their use as sedative agents |
| 05/05/1987 | US4663318 Method of treating Alzheimer's disease |
| 05/05/1987 | CA1221308A1 N-acetyl-p-aminophenol composition containing partially gelatinized starch and method for preparing same |
| 04/29/1987 | EP0220143A1 New pharmaceutical preparation with controlled release of metoprolol, a method for the manufacture thereof and the use of the new preparation |
| 04/29/1987 | EP0220129A2 12- and 13-substituted ergoline derivatives |
| 04/29/1987 | EP0219934A1 Process for the preparation of aryl-piperidine esters |
| 04/29/1987 | EP0219706A1 N,N-dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizine-3-carboxamides |
| 04/28/1987 | US4661630 Nervous system disorders |
| 04/28/1987 | US4661618 Stimulation of brain cells and mental activity; antiaging agents |
| 04/28/1987 | US4661513 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them |
| 04/28/1987 | US4661502 Enzyme inhibitors |
| 04/28/1987 | US4661498 Furo 3,2-c pyridine derivatives and their use in treating depression and cerebral ischemia |
| 04/28/1987 | US4661492 Buprenorphine and naltrexone |
| 04/28/1987 | US4661491 Alfuzosine compositions and use |
| 04/28/1987 | US4661482 Use of pyrazolobenzoxazines in method of treating cerebral senescence and cerebral hypoxin |
| 04/23/1987 | WO1987002242A1 Improvements in and relating to effervescent acetylsalicylic acid tablets |
| 04/23/1987 | WO1987002219A1 Alpha tocopherol-based vesicles |
| 04/22/1987 | EP0219377A1 Process for the preparation of spherical paracetamol agglomerates and products obtained thereby |
| 04/22/1987 | EP0219350A2 Ethanolamine compounds |
| 04/22/1987 | EP0219337A2 Improvements in and relating to effervescent acetylsalicylic acid tablets |
| 04/22/1987 | EP0219276A2 Vitamin-containing granules and production thereof |
| 04/22/1987 | EP0219258A2 Peptide antagonists of Neurokinin B and opthalmic solutions containing them |
| 04/22/1987 | EP0219193A1 Tetrahydrocarbazolone derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 04/22/1987 | EP0218999A2 New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them |
| 04/22/1987 | CN86105229A Oculoselective beta-blockers |
| 04/21/1987 | US4659834 Process for the preparation of fluoromethyl-quinoline derivatives |
| 04/21/1987 | US4659833 Four optical isomers of 1-(2'-(o-methoxyphenyl)-1'-methylethylamino)-3-(4"-isocarbostyriloxy)-2 -propanol isolated by liquid chromatography |
| 04/21/1987 | US4659741 β-[2-(halogenobenzyl)-phenoxy]-ethylamine derivatives |
| 04/21/1987 | US4659729 Novel 4H-1,2,4-triazole derivatives |
| 04/21/1987 | US4659727 Ethene derivatives |
| 04/21/1987 | US4659710 1,7-Naphthyridine derivatives and pharmaceutical compositions |
| 04/21/1987 | US4659707 Antiulcer, antisecretory, antimuscarinic and/or antispasmodic agents |
| 04/21/1987 | CA1220783A1 Diphenylazomethines bearing an imidazolyl group, their preparation and pharmaceutical compositions containing them |
| 04/21/1987 | CA1220736A1 Human nerve growth factor by recombinant technology |
| 04/21/1987 | CA1220718A1 Pharmaceutical composition fo valproic acid and preparation process thereof |
| 04/15/1987 | EP0218541A2 3-Vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments |
| 04/15/1987 | EP0218460A2 Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus. |
| 04/15/1987 | EP0218440A2 N-Methylphenylserine alkyl ester derivatives and uses thereof |
| 04/15/1987 | EP0218433A1 Selective method for blocking 5HT2 receptors |
| 04/15/1987 | EP0218373A2 Chroman derivatives and analogues having antihypertensive activity |
| 04/15/1987 | EP0218195A2 Bis(dibenzo[b,d]pyranyloxy)propanes |
| 04/15/1987 | EP0218190A2 Macromolecular CDP-choline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/15/1987 | EP0218077A1 8-Chlorodibenz[b,f] [1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylthio-, phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides |
| 04/15/1987 | EP0218068A1 Dihydropyridine-2-hydroxyamines, process for their preparation and their use in medicaments |
| 04/14/1987 | USRE32400 Substituted imidazole derivatives and their use as anti-thrombosis agents |
| 04/14/1987 | US4658037 Rheumatic diseases |
| 04/14/1987 | US4657910 Treatment of cerebrovascular disorders and/or disorders associated with cerebral senility |
| 04/14/1987 | US4657899 Antagonists of specific excitatory amino acid neurotransmitter receptors |
| 04/14/1987 | CA1220486A1 Process for preparing new n-(4-acetylaminophenacyl)- amine derivatives |
| 04/14/1987 | CA1220472A1 1,4-benzodiazepine derivatives |
| 04/09/1987 | WO1987002035A1 Fused cycloaliphatic aminoalcohols |
| 04/08/1987 | EP0217737A2 Tetrahydro-beta-carbolines, process for their preparation and their use as medicaments |
| 04/08/1987 | EP0217736A2 1,2-Disubstituted ergoline derivatives |
| 04/08/1987 | EP0217735A2 2-Substituted ergoline derivatives |
| 04/08/1987 | EP0217734A1 12- or 13-bromoergoline derivatives |
| 04/08/1987 | EP0217688A1 Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them |
| 04/08/1987 | EP0217287A2 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts |
| 04/08/1987 | EP0217258A2 The use of choline or choline releasing compounds in the production of pharmacological compositions capable of reducing fatigue |
| 04/08/1987 | EP0217135A1 Spiro[benzofuran-2(3H), 1'cycloheptane]s, a process and intermediates for their preparation and their use as medicaments |
| 04/08/1987 | EP0216936A1 Novel tannin composition |
| 04/08/1987 | CN86106588A Pharmaceutical preparation |
| 04/08/1987 | CN86106163A Novel henzodiozepanne, process for the synthesis thereor and uses thereor in therapectics. |
| 04/07/1987 | US4656305 Chalcone derivatives |
| 04/07/1987 | US4656298 Muscle relaxants, stimulants, analgesics, anticonvulsants, antidepressants |
| 04/07/1987 | US4656179 Isoquinoline derivatives, and pharmaceutical compositions containing them |
| 04/07/1987 | US4656173 Antipsychotic benzisothiazole S-oxide compound |
| 04/07/1987 | US4656169 Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions |
| 04/07/1987 | US4656167 Naphthoxazines and their use as psychostimulating and antidepressant agents |
| 04/07/1987 | CA1220225A1 Diethyl-amino-alkoxy-benzhydrol derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/07/1987 | CA1220224A1 Preparation of n-(methoxyphenacyl)-amine derivatives |
| 04/07/1987 | CA1220214A1 .beta.-OXO-.alpha.-CARBAMOYL-PYRROLEPROPIONITRILES |
| 04/07/1987 | CA1220200A1 Process for the preparation of levallorphan halomethylates and pharmaceutical compositions having peripheral opiate antagonistic activity containing them |
| 04/07/1987 | CA1220199A1 Process for obtention of peripheral opiate antagonists |
| 04/07/1987 | CA1220141A1 Treatment of migraine with tropyl benzoate derivatives |
| 04/01/1987 | EP0216658A1 Benzodioxepane, process for its preparation and its therapeutical use |
| 04/01/1987 | EP0216555A2 Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections |
| 04/01/1987 | EP0216247A2 Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions |
| 04/01/1987 | EP0216133A1 Nutritional agent for the cerebrospinal nervous system |
| 04/01/1987 | EP0216072A2 Use of dibenz[cd,f]indole derivatives in the prevention of alcohol abuse |
| 04/01/1987 | CN86104358A Method for preparing ortho-azonaphthalene compound |
| 03/31/1987 | US4654372 Method for using verapamil for treating stroke |
| 03/31/1987 | US4654351 Bis(substituted methyl)-methyl-isoquinoline derivatives and pharmaceutical compositions containing them |